Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.20.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period at Dec. 31, 2018 $ 552,568 $ 33 $ (108,637) $ 569,712 $ (6,079) $ 97,539
Beginning balance, shares issued (shares) at Dec. 31, 2018   33,202,369        
Beginning balance, treasury stock (shares) at Dec. 31, 2018     (2,273,932)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2018   30,928,437        
Stock options exercised 8     8    
Stock options exercised (shares)   650        
Restricted stock awards, net of forfeitures (shares)   (49,131)        
Share-based compensation expense 712     712    
Restricted stock surrendered due to employee tax liability (425)   $ (425)      
Restricted stock surrendered due to employee tax liability (shares)   (19,423) (19,423)      
Cash dividends declared (common stock, $0.24/share) (7,440)         (7,440)
Net income 14,672         14,672
Change in unrealized gain (loss) on securities available for sale, net of income taxes 4,197       4,197  
Balance at end of period at Mar. 31, 2019 564,292 $ 33 $ (109,062) 570,432 (1,882) 104,771
Ending balance, shares issued (shares) at Mar. 31, 2019   33,153,888        
Ending balance, treasury stock (shares) at Mar. 31, 2019     (2,293,355)      
Ending balance, shares outstanding (shares) at Mar. 31, 2019   30,860,533        
Adjustments related to adoption of new accounting standards | ASU 2016-13 (12,167)         (12,167)
Balance at beginning of period at Dec. 31, 2019 $ 563,267 $ 33 $ (116,515) 575,816 3,382 100,551
Beginning balance, shares issued (shares) at Dec. 31, 2019   33,475,402        
Beginning balance, treasury stock (shares) at Dec. 31, 2019 (2,675,778)   (2,675,778)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2019   30,799,624        
Adjusted balance at Dec. 31, 2019 $ 551,101 $ 33 $ (116,515) 575,816 3,382 88,385
Restricted stock awards, net of forfeitures (shares)   (27,188)        
Share-based compensation expense 769     769    
Restricted stock surrendered due to employee tax liability (171)   $ (171)      
Restricted stock surrendered due to employee tax liability (shares)   (14,295) (14,295)      
Repurchase of common stock (2,196)   $ (2,196)      
Repurchase of common stock (shares)   (135,400) (135,400)      
Cash dividends declared (common stock, $0.24/share) (7,380)         (7,380)
Net income 2,350         2,350
Change in unrealized gain (loss) on securities available for sale, net of income taxes 8,485       8,485  
Balance at end of period at Mar. 31, 2020 $ 552,958 $ 33 $ (118,882) $ 576,585 $ 11,867 $ 83,355
Ending balance, shares issued (shares) at Mar. 31, 2020   33,448,214        
Ending balance, treasury stock (shares) at Mar. 31, 2020 (2,825,473)   (2,825,473)      
Ending balance, shares outstanding (shares) at Mar. 31, 2020   30,622,741